Study of fucosylated chondroitin sulfate from Cucumaria frondosa on hyperglycemic effects and insulin resistance improvement
-
摘要: 以高脂高糖饲料(high-fat high-sucrose,HFSD)饲喂法建立胰岛素抵抗小鼠模型。研究了冰岛刺参岩藻糖基化硫酸软骨素(fucosylated chondroitin sulfate from the sea cucumber Cucumaria frondosa,Cf-CHS)对胰岛素抵抗小鼠的降血糖及改善胰岛素抵抗作用。雄性C57BL/6J小鼠随机分为正常对照(标准饲料)、模型对照(HFSD)、阳性对照(HFSD+rosiglitazone(RSG),1mg·(kg·d)-1)、Cf-CHS组(HFSD+Cf-CHS,80mg·(kg·d)-1)及Cf-CHS+RSG组(HFSD+Cf-CHS+RSG,80+1mg·(kg·d)-1)。各组小鼠自由摄食摄水19周。实验结束后,称重小鼠白色脂肪质量,检测空腹血糖、血清胰岛素及血清脂联素、抵抗素、瘦素、肿瘤坏死因子-α(TNF-α)水平。实验结果表明:Cf-CHS可显著降低胰岛素抵抗小鼠的脂肪积累(p<0.01),降低血糖(p<0.01)和胰岛素(p<0.05)水平,改善胰岛素抵抗(p<0.05),提高血清脂联素含量(p<0.05),降低抵抗素(p<0.01)、瘦素(p<0.01)和TNF-α(p<0.05)含量。Cf-CHS与RSG复配使用,效果更显著(p<0.05,p<0.01)。Cf-CHS能显著改善胰岛素抵抗小鼠的高血糖症状及胰岛素抵抗程度,其作用机制可能与改善肥胖引起的脂肪细胞因子的分泌紊乱有关。
-
关键词:
- 冰岛刺参 /
- 岩藻糖基化硫酸软骨素 /
- 血糖 /
- 胰岛素抵抗 /
- 脂肪细胞因子
Abstract: The model mice was established by feeding a diet of high-fat high-sucrose diet ( HFSD) .The aim of the present study was to unravel the effects of fucosylated chondroitin sulfate from Cucumaria frondosa ( Cf-CHS) on hyperglycemic effects and insulin resistance improvement in insulin resistant mice. Male C57BL /6 mice were randomly assigned into the normal control ( standard diet) , model control ( HFSD) , positive control ( HFSD +rosiglitazone ( RSG) , 1mg· ( kg·d) - 1) , Cf-CHS ( HFSD + + Cf-CHS, 80mg· ( kg·d) - 1) , Cf-CHS + RSG ( HFSD + Cf-CHS + RSG, 80 + 1mg· ( kg·d) - 1) groups. All animals fed with diet and water freely for 19 weeks. After experiments, the white fat weight, fasting serum glucose, serum insulin, serum adiponectin, resistin, leptin, and tumor necrosis factor- α ( TNF- α) levels were determined. Results showed that Cf- CHS markedly decreased fat deposition ( p < 0.01) , blood sugar ( p < 0.01) and insulin ( p < 0.05) levels, ameliorated insulin resistance ( p < 0.05) , increased serum adiponectin concentration ( p < 0.05) , and lowered serum resistin ( p < 0.01) , leptin ( p < 0.01) , TNF-α ( p < 0.05) levels.The effect was more significant when Cf- CHS compounded with RSG ( p < 0.05, p < 0.01) .Cf-CHS significantly decreased blood glucose level and ameliorated insulin resistance in insulin resistant mice, and the mechanisms may involved the regulation of adipocytokines parasecretion caused by adiposity. -
[1] sacks DB.Amylin-aglueo regulatory hormone involved in hepatho-genesis of diabetes mellitus[J].Clin Chem, 1996, 42:494.
[2] gumell M, Savage DB, Chatterjee VK, et al.Insulin resistance in non-insulin-dependent diabetes mellitus[J].J Clin Endocrinol Metab, 2003, 88 (6) :2412-2421.
[3] Lubor Borsig, Lianchun Wang, Moises CM Cavalcante, et al.Selectin Blocking Activity of a Fucosylated Chondroitin Sulfate Glycosaminoglycan from Sea Cucumber[J].The Journal of Biological Chemistry, 2007, 282:14984-14991.
[4] Shiguo Chen, Yaqin Hu, Xinqian Ye, et al.Sequence determination and anticoagulant and antithrombotic activities of a novel sulfated fucan isolated from the sea cucumber Isostichopus badionotus[J].Biochimica et Biophysica Acta, 2012, 1820:989-1000.
[5] 李辉, 王静凤, 张徇.海参硫酸软骨素抑制小鼠黑色素瘤肺转移作用的研究[J].中国药理学通报, 2011, 27 (5) :623-628. [6] 陈士国, 李国云, 尹利昂, 等.高温1H NMR鉴别8种海参硫酸软骨素[J].分析测试学报, 2010, 29 (8) :782-786. [7] 李国云, 尹利昂, 陈士国, 等.海参多糖硫酸根含量的离子色谱法测定及其差异分析[J].分析检测, 2011, 32 (7) :403-406. [8] Pereira RI, Draxnin B.Inhibition of the phosphatidylionsitol3’-kinase signaling pathway leads to decrease insulin-stimulated adiponectin secretion from 3T3-L1 adiposities[J].Metabolism, 2005, 54 (12) :257-263.
[9] 魏学娟, 翁孝刚, 张一平, 等.黄芪多糖对大鼠胰岛素抵抗的治疗作用[J].中国实验方剂学杂志, 2011, 17 (11) :238-242. [10] Sang WK, Hye JH, Yu MB, et al.Proteomic analysis in ob/ob mice before and after hypoglycemic polysaccharide treatments[J].Journal of Microbiology and Biotechnology, 2009, 19 (10) :1109-1121.
[11] 金智生, 汝亚琴, 李娟娥, 等.红芪多糖对实验性大鼠糖尿病胰岛素抵抗瘦素的影响[J].中西医结合心脑血管病杂志, 2010, 8 (10) :1215-1217. [12] Ji-Hye K, Goto T, In-Seob H, et al.Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet[J].Nature, 2010, 18 (4) :780-787.
[13] Martens FM, Visseren FL, Lemay J, et al.Metabolic and additional vascular effects of thiazolidinediones[J].Drugs, 2002, 62:1463-1480.
[14] Hemmeryckx B, Hoylaerts MF, Gallacher DJ, et al.Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?[J].Eur J Pharmacol, 2013, 700:23-31.
[15] Komajda M, McMurray JJV, Beck-Nielsen H, et al.Heart failure events with rosiglitazone in type 2 diabetes:data from the RECORD clinical trial[J].Eur Heart J, 2010, 31:824-831.
[16] Cohen A, Rabbani A, Shah N, et al.Changes in glitazone use among office-based physicians in the US, 2003-2009[J].Diabetes Care, 2010, 33:823-825.
[17] 周燕, 汤凤莲, 蔡姗姗.罗格列酮对阻塞性睡眠呼吸暂停综合征模型血清和脂肪组织抵抗素、瘦素表达的影响[J].中国药理学通报, 2013, 29 (1) :94-98. [18] 邓宏明, 刘红, 邓华聪, 等.罗格列酮改善2型糖尿病患者体脂分布\脂联素水平和组织胰岛素敏感性[J].中华内分泌代谢杂志, 2005, 21 (3) :233-236.
计量
- 文章访问数:
- HTML全文浏览量:
- PDF下载量: